Replacement therapy in Addison’s disease

Author： Løvås Kristian   Husebye Eystein S  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.12, 2003-12, pp. : 2145-2149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucocorticoid replacement therapy in patients with Addison’s disease

By Kyriazopoulou Venetsana  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 725-729

Informa Healthcare

Access to resources Recommend Favorite

Addison’s disease masked by long term exogenous steroid treatment for presumed polymyalgia rheumatica

By Ankcorn Mike   Nag Sath  

Clinical Medicine, Vol. 12, Iss. 1, 2012-02 ,pp. : 89-90

Royal College Of Physicians

Access to resources Recommend Favorite

-Galactosidase replacement therapy in Fabry's disease

By  

Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Role of Nanotechnology for Enzyme Replacement Therapy in Lysosomal Diseases. A Focus on Gaucher’s Disease

By  

Current Medicinal Chemistry, Vol. 23, Iss. 9, 2016-03 ,pp. : 929-952

Bentham Science Publishers

Access to resources Recommend Favorite

Enzyme Replacement Therapy in Patients with Fabry's Disease

By Tsuboi K  

The Journal of International Medical Research, Vol. 35, Iss. 4, 2007-07 ,pp. : 574-581

Field House Publishing

Access to resources Recommend Favorite